Body / AbdominalNuclear / MolecularNews

Study: 18F-flotufolastat PET/MRI Could Cut Prostate Biopsies by Over 50%

Reporting Systems watch (Google News)4d ago

18F-flotufolastat PET/MRI may reduce unnecessary prostate biopsies by more than 50%, according to a new study (exact figure not reported in source).

  • The news summary did not provide study design, sample size, or statistical measures.
  • 18F-flotufolastat is a PSMA-targeted PET tracer used with MRI for prostate cancer evaluation.
  • Limitation: Full study details are unavailable; findings are based on a news summary without peer-reviewed data.
Read the source

Also covered by

RadPigeon summaries are original and for information only. They are not clinical advice.